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BY-NC-ND license (http://creativecomBackground/purpose: Gastroesophageal reflux disease (GERD) is an emerging disease, and can
impair quality of life and sleep. This study aimed to investigate whether GERD patients with
different timings of reflux symptoms have different clinical characteristics.
Methods: This study prospectively enrolled individuals who underwent upper gastrointestinal
endoscopy during a health checkup. Each participant completed all questionnaires including
Reflux Disease Questionnaire, Nighttime GERD questionnaire, Pittsburg Sleep Quality Index,
Taiwanese Depression Questionnaire, and State-Trait Anxiety Inventory. Combined reflux
was defined as the timing of reflux symptoms occurring at both daytime and nighttime.
Results: A total of 2604 participants were enrolled. Of them, 651 symptomatic GERD patients,
according to the Reflux Disease Questionnaire score, were recruited for final analysis. Of them,
224 (34.4%) had erosive esophagitis on endoscopy. According to the timing of reflux symptoms,
184 (28.3%) were assigned to the daytime reflux group, 71 (10.9%) to the nighttime reflux
group, and 396 (60.8%) to the combined reflux group. In post hoc analysis, the combined reflux
group had a significantly higher Reflux Disease Questionnaire score than the daytime reflux
group (p < 0.0001). Combined and nighttime reflux groups had higher body mass index and
longer duration (> 12 years) of education than the daytime reflux group (p < 0.05). There
was no difference in Pittsburg Sleep Quality Index, Taiwanese Depression Questionnaire, and
State-Trait Anxiety Inventory scores among three groups.ave no conflicts of interest relevant to this article.
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124 J.-H. Chen et al.Conclusion: GERD patients with combined daytime and nighttime reflux of have more trouble-
some symptoms than those with daytime reflux. GERD patients with different timings of reflux
symptoms have different clinical characteristics in terms of body mass index and duration of ed-
ucation, but not in terms of esophageal inflammation, quality of sleep, and psychosocial status.
Copyright ª 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).Introduction
Gastroesophageal reflux disease (GERD) is the most common
gastrointestinal diagnosis in outpatient clinics, incurring
high expenses across the world.1 The incidence increases
fivefold in most Western countries and appears to be rising in
some developed Asian countries.2 It can reduce the quality
of life and complicate life with esophagitis, bleeding, stric-
ture, or even esophageal adenocarcinoma.3 In clinical
practice, the diagnosis depends on the typical reflux symp-
toms, including heartburn and/or acid regurgitation. How-
ever, not all the patients with typical reflux symptoms have
the evidence of mucosal injury on endoscopy.4 Patients with
GERD can be categorized according to the timing of reflux
symptoms they predominantly experience. Several recent
studies have demonstrated that nighttime symptoms are not
unusual, affecting between 72% and 79% of GERD
patients.5e7 Frequent nighttime heartburn has been re-
ported to impair health-related quality of life and work
productivity of GERD patients compared with minimal or no
nighttime symptoms.8 In addition, recent studies have also
demonstrated poor quality of sleep and sleep disturbances
among patients with nighttime GERD.9e11
There is scanty information about clinical characteristics
in GERD patients with nighttime symptoms versus those
with other timings of reflux symptoms. Furthermore, there
are no data on the impact of nighttime reflux on the status
of mood such as anxiety and depression. Thus, our study
aimed to examine, using a large-scale health examination
cohort, whether GERD patients, categorized based on the
timing of reflux symptoms, have different characteristics
and psychological comorbidities.Methods
Study participants
A total of 2752 participants who came to the Health Exami-
nation Centers of Taipei, Tiawan and Hualien Tzu Chi Hos-
pital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan
for medical check-up from March 2012 to August 2013 were
recruited in the study. Individuals aged younger than
20 years or older than 70 years and with insufficient answers
to the questionnaires (nZ 163) were excluded. Of them, 651
whowere diagnosed to have symptomatic GERD according to
the Reflux Disease Questionnaire (RDQ) score were recruited
for the final analysis. The RDQwas an instrument used for the
diagnosis of symptomatic GERD and previously validated in
Chinese populations.12e14 The time of reflux symptoms
including heartburn and/or acid regurgitation within theprevious 3 months was determined using nighttime gastro-
esophageal reflux disease (NTG) questionnaire. According to
the NTG questionnaire, these individuals were divided into
three groups: “daytime group” including adults who expe-
rience only daytime symptoms, “nighttime group” including
adults who experience only nighttime symptoms, and
“combined group” defined as adults who experience both
daytime and nighttime symptoms. Nighttime symptomswere
defined as reflux symptoms occurring at the time of going to
bed, in sleep, or just after waking up. The daytime group
included adults with reflux symptoms at least 1 day per week
but without nighttime symptoms, and the nighttime group
included adults with reflux symptoms at least 1 night per
week but without daytime symptoms. The combined group
consisted of adults with both daytime and nighttime reflux
symptoms at least once per week. The ethics committees of
Taipei and Hualien Tzu Chi Hospital, Buddhist Tzu Chi Med-
ical Foundation approved this study, and each participant
provided informed consent.
Questionnaires
In this study, a face-to-face interview was conducted using
a questionnaire during the health examination visit. The
questionnaires included RDQ, NTG questionnaire, Pittsburg
Sleep Quality Index (PSQI), Taiwanese Depression Ques-
tionnaire (TDQ), and State-Trait Anxiety Inventory (STAI).
The RDQ was an instrument used for the diagnosis of
symptomatic GERD. It examined symptoms of heartburn,
acid regurgitation, and dyspepsia, and included 12 ques-
tions regarding the frequency and severity of burning and
pain behind the breastbone, acidic taste in the mouth,
movement of materials upward from the stomach, and
burning and pain in the upper stomach.15,16 The response
option was scaled from 0 to 5 points. After excluding the
dyspepsia scale, scores of RDQ ranged from 0 to 40. The
PSQI was an effective instrument for measuring the quality
and patterns of sleep by examining seven domains: sub-
jective sleep quality, sleep latency, sleep duration,
habitual sleep efficiency, sleep disturbances, use of sleep
medication, and daytime dysfunction over the past month.
Scoring of answers ranges from 0 to 3, with a sum score of 
5 indicating a “poor” sleeper.17 The TDQ has 18 items with a
4-point scale. It is a culturally specific depression instru-
ment, effective for screening of depression in Taiwanese
people and has satisfactory reliability and validity.18 The
participants were guided to rate each item on a scale from
0 to 3 on the basis of “how often you felt the physical and
emotional aspects during the past week.” TDQ scores range
from 0 to 54. The STAI is a commonly used measurement of
trait and state anxiety.19 It can be used in clinical settings
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dromes. It has 20 items for assessing trait anxiety, along
with 20 items for state anxiety. All items are rated on a 4-
point scale (e.g., from “almost never” to “almost always”);
hence, higher scores indicate greater anxiety.Demographic and medical information
Demographic data were collected, including gender, age,
body mass index (BMI), education, family income, and his-
tory of diabetes mellitus, hypertension, and hyperlipid-
emia. Furthermore, medical information related to GERD
was included. Esophagogastroduodenoscopy was performed
on each participant. Standardized sedated endoscopic ex-
amination of the esophagus, stomach, and duodenum was
performed, and erosive esophagitis was graded from A to D
according to the Los Angeles classification.20 Experienced
endoscopists, who were blinded to the results of the
questionnaires, performed all the procedures. Any discor-
dance in the diagnosis needed discussion, and the final
diagnosis was made by consensus of three experienced
endoscopists. An autoanalyzer measured serum fasting
blood glucose, triglyceride, total cholesterol, low-density
lipoprotein, and high-density lipoprotein (Roche analytics;
Roche Professional Diagnostics, Penzberg, Germany).
Metabolic syndrome was determined based on the National
Cholesterol Education Program Adult Treatment Panel III as
the presence of at least three of the following five char-
acteristics: the presence of abdominal obesity (a waist
circumference of  90 cm for Taiwanese men and  80 cm
for Taiwanese women), triglyceride concentration Table 1 Demographic data and questionnaire scores among thr
Time of reflux symptoms Daytime (n Z 184) Nightt
Male 94 (51.1) 47 (66
Age (y) 51.35  9.74 49.73
BMI (kg/m2) 23.67  3.36 25.09
WHR 0.88  0.08 0.90 
Duration of education (y)
<9 42 (22.8) 11 (15
9e12 62 (33.7) 16 (22
>12 80 (43.5) 44 (62
Income
Enough 106 (57.6) 35 (49
Rich 70 (38) 33 (46
Poor 8 (4.4) 3 (4.2
Clinic for GERD 94 (51.1) 28 (39
Questionnaire
RDQ score 5.14  5.13 5.37 
PSQI score 6.49  2.10 6.48 
PSQI 5 33 (17.9) 14 (19
Depression: TDQ score 26.68  7.18 27.68
Anxiety: STAI score 42.65  6.12 42.92
BMI Z body mass index GERD Z gastroesophageal reflux disease;; P
tionnaire; STAIZ State-Trait Anxiety Inventory; TDQ Z Taiwanese De
Data are presented as n (%) or mean (standard deviation).
a Between daytime and nighttime.
b Between daytime and combined.
c Between nighttime and combined.150 mg/dL, high-density lipoprotein cholesterol
concentration < 40 mg/dL in men and < 50 mg/dL in
women, systolic blood pressure  130 mmHg or diastolic
blood pressure  85 mmHg; or fasting plasma
glucose  100 mg/dL.21
Statistical analysis
Categorical data were presented as percentages, while
continuous data were presented as the mean with standard
deviations. Chi-square test and analysis of variance fol-
lowed by Turkey’s post hoc test were used to analyze cat-
egorical and continuous variables, respectively. The
association between NTG status and potential risk factors
was measured by odds ratio. The nighttime and mixed
groups were compared with the daytime group (i.e., the
reference group). Adjusted odds ratios and 95% confidence
intervals as well as p values were estimated based on
stepwise multiple logistic regression. All analyses were
performed using SAS version 9.2 (SAS Institute, Cary, NC,
USA). All tests were two sided, and p < 0.05 was considered
statistically significant.Results
Demographic and clinical characteristics of GERD
patients with different timings of reflux symptoms
A total of 651 GERD patients were recruited for the final
analysis. Of them, 224 (34.4%) had erosive esophagitis onee different time groups of GERD patients.
ime (n Z 71) Combined (n Z 396) p
.2) 226 (57.1) 0.08
 11.09 49.61  9.69 0.13
 4.04 24.68  3.79 0.003 a,b
0.08 0.88  0.08 0.55
0.02
.5) 59 (14.9)
.5) 139 (35.1)
) 198 (50)
0.5
.3) 210 (53)
.5) 159 (40.2)
) 27 (6.8)
.4) 239 (60.4) 0.002
5.47 8.75  6.87 <0.0001 b,c
2.06 6.81  2.37 0.22
.7) 62 (15.7) 0.61
 7.83 29.65  9.6 0.001 b
 7.38 42.83  6.18 0.93
SQIZ Pittsburg Sleep Quality Index; RDQ Z reflux disease ques-
pression Questionnaire; WHR Z waistehip ratio.
Table 2 Comparison of clinical data among three different time groups of GERD patients.
Factors Daytime (n Z 184) Nighttime (n Z 71) Combined (n Z 396) p
Erosive esophagitis 61 (33.2) 24 (33.8) 139 (35.1) 0.89
Hiatus hernia 9 (5) 5 (7) 15 (4.1) 0.54
Helicobacter pylori 47 (25.8) 18 (25.4) 80 (20.5) 0.31
Hypertension 27 (15.8) 10 (14.7) 70 (18.6) 0.59
Diabetes mellitus 10 (5.9) 5 (7.4) 31 (8.2) 0.61
Hyperlipidemia 24 (14) 11 (16.2) 48 (12.8) 0.73
Metabolic syndrome 46 (25) 22 (31) 131 (33.1) 0.14
Waist (cm) 84.04  10.25 87.17  11.52 85.51  10.63 0.09
Systolic blood pressure (mmHg) 118.79  16.06 117.12  14.13 120.32  15.54 0.23
Diastolic blood pressure (mmHg) 73.92  12.79 74.64  11.80 74.90  12.10 0.69
Glucose (mg/dL) 95.49  18.72 98.31  19.07 99.20  24.75 0.19
Cholesterol (mg/dL) 196.68  40.10 195.97  41.17 193.05  36.82 0.54
Triglyceride (mg/dL) 115.29  68.75 139.01  102.46 130.35  83.74 0.05
HDL (mg/dL) 52.07  14.01 48.03  14.64 48.53  13.90 0.01a
GERD Z gastroesophageal reflux disease; HDL Z high-density lipoprotein.
Data are presented as n (%) or mean (standard deviation).
a Between daytime and combined.
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184 (28.3%) were in the daytime group, 71 (10.9%) in the
nighttime group, and 396 (60.8%) in the combined group.
The demographic and clinical data are shown in Tables 1
and 2. The combined group had a higher RDQ score than
the daytime or nighttime group (p < 0.0001). The com-
bined group had a significantly higher TDQ score than the
daytime group (p Z 0.0006). Among the three groups,
there was a significant difference in BMI, duration of ed-
ucation, and clinic for GERD and serum high-density lipo-
protein levels. However, age, sex, income, diabetes
mellitus, hypertension, hyperlipidemia, metabolic syn-
drome, serum glucose, triglyceride, cholesterol, waist
circumference, blood pressure, and PSQI and STAI scores
were comparable among the three groups. There was alsoTable 3 Comparison of clinical factors in patients with either ni
multivariate stepwise logistic regression analyses.a
Nighttime
Variable factors OR 95% CI
Female gender 0.747 0.401e1.392
Age 1.001 0.97e1.032
Duration of education (Ref.b < 9 y)
9e12 y 0.948 0.386e2.326
>12 y 2.136 0.909e5.018
BMI 1.133 1.033e1.244
Clinic for GERD 0.773 0.425e1.405
RDQ score 0.99 0.933e1.051
TDQ score 1.021 0.979e1.066
Metabolic syndrome 0.923 0.447e1.905
BMIZ body mass index; CIZ confidence interval; GERDZ gastroesoph
PSQIZ Pittsburg Sleep Quality Index; RDQ Z reflux disease que
Questionnaire.
a OR and 95% CI were obtained from multivariate logistic regressio
score, PSQI score, and MS.
b Ref. means that category served as the reference group for calcuno significant difference in the presence of erosive
esophagitis, hiatus hernia, or Helicobacter pylori infection
among the three groups.Clinical factors in patients with nighttime or
combined reflux symptoms compared with those
with daytime reflux symptoms, using multivariate
stepwise logistic regression analyses
After adjustment with age, sex, duration of education, BMI,
clinic for GERD, RDQ score, TDQ score, and metabolic
syndrome, multivariate logistic regression analysis showed
that the combined group had a higher RDQ score than the
daytime or nighttime group (p < 0.0001). Furthermore, theghttime or combined symptoms with daytime symptoms using
Combined
p OR 95% CI p
0.36 0.855 0.58e1.259 0.43
0.97 0.994 0.973e1.016 0.59
0.22 1.846 1.067e3.194 0.27
0.02 2.15 1.23e3.759 0.03
0.01 1.091 1.022e1.164 0.01
0.40 1.374 0.932e2.023 0.11
0.75 1.093 1.054e1.133 <0.0001
0.32 1.025 0.999e1.051 0.06
0.83 1.169 0.717e1.906 0.53
ageal reflux disease; MSZmetabolic syndrome; ORZ odds ratio;
stionnaire; Ref. Z reference; TDQ Z Taiwanese Depression
n adjusted for gender, age, education, BMI, clinic for GERD, RDQ
lating an OR.
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duration (> 12 years) of education than the daytime group
(Table 3).Discussion
In this study of 651 symptomatic GERD patients from a
health examination center, 224 (34.4%) had erosive esoph-
agitis on endoscopy and 467 (71.7%) suffered from night-
time reflux. In post hoc analysis, patients with combined
daytime and nighttime reflux had a higher RDQ score than
those with daytime reflux only, suggesting that the severity
of reflux symptoms was higher in patients having reflux
symptoms during both daytime and nighttime. In addition,
higher BMI and education level were factors associated with
nighttime reflux.
Nighttime reflux symptoms are common in GERD pa-
tients.22,23 A large sample study revealed that 72% of GERD
patients had typical nighttime reflux symptoms. Among 1000
adults experiencing heartburn at least once per week,
assessed using a nationwide telephone survey, 79% had
heartburn at night. In our study, 60.8% of GERD patients had
combined daytime and nighttime reflux, and 10.9% had iso-
lated nighttime reflux, which was comparable with the
findings of previous studies. Our study divided nocturnal
GERD patients into two groups, combined daytime and
nighttime reflux group and isolated nighttime reflux group,
which helped in better understanding of the nighttime reflux.
Nocturnal GERD can produce more severe consequences
than daytime GERD, especially in the quality of sleep and
productivity of daytime work.24 Furthermore, patients with
nighttime reflux symptoms had a higher score of “GERD
symptom and medication questionnaire” than those with
exclusively daytime symptoms.25 Using 24-hour esophageal
PH monitoring, the number of reflux events lasting > 5 mi-
nutes and acid contact time were significantly greater in
patients with nighttime heartburn than in those without it
for the total and upright position time.26 In our study, those
with combined daytime and nighttime reflux had more se-
vere reflux symptoms than those with daytime reflux, but
there was no difference compared with those with isolated
nighttime reflux. Taking these results together, nighttime
reflux is more troublesome than daytime reflux.
In a study of 50 GERD patients who received intra-
esophageal PHmonitoring during nighttime, it was found that
the number of acid reflux, time of PH < 4, and frequency of
PH < 4 during nighttime were significantly lower in non-
erosive reflux disease (NERD) patients compared with pa-
tients with erosive esophagitis.27 It suggested that the
severity of intraesophageal acid exposure during nighttime
might cause the difference between NERD and erosive
esophagitis patients. By contrast, our results showed no dif-
ference in the presence of erosive esophagitis on endoscopy
among patients of the daytime, nighttime, or combined
group. The inconsistent finding can be explained due to
dissociation between the severity of reflux symptom and the
intensity of intraesophageal PH.
Obesity is a well-known risk factor of GERD.28 However,
studies investigating the association of nighttime reflux
with obesity are scarce. In a large prospective cohort study,
increased BMI was found to be associated with heartburnduring sleep.9 Our results showed that the nighttime or
combined group of GERD patients had higher BMI than the
daytime group. It suggests that obesity may play an
important role in the development of nighttime reflux.
It is an interesting finding about the association between
duration of education and the timing of reflux symptoms in
our study. Patients either with combined daytime and
nighttime reflux or with isolated nighttime reflux have a
higher frequency of longer duration (> 12 years) of edu-
cation than those with daytime reflux. As we know, people
get knowledge from education and knowledge can affect
their behavior including dietary habit, exercise, and life-
style.29,30 However, a better understanding of the complex
interplay between education, behavior, and disease
pattern needs additional studies.
Whether nighttime reflux can affect the quality of sleep
is an important issue. In a study using a telephone survey,
75% of nocturnal GERD patients reported impaired sleep
quality.7 Using the PSQI questionnaire, patients with
nighttime heartburn had significantly impaired subjective
sleep quality compared to those without it.24 Two previous
studies have shown that esomeprazole improved both
heartburn symptoms and sleep quality compared with pla-
cebo in patients having both moderate-to-severe nighttime
heartburn and sleep disturbance, providing further evi-
dence on the adverse impact of nighttime heartburn on
sleep quality.31,32 However, our results failed to demon-
strate the difference of sleep quality among patients with
daytime, nighttime, or combined reflux. The possible
explanation is relatively mild reflux symptoms in this study
population from a health examination center.
This study has several strengths. In literature, symptom-
atic GERD is usually divided into two types according to the
time of reflux symptoms: one is daytime GERD and the other
is nocturnal GERD, which is defined as the presence of
nighttime reflux regardless of whether daytime reflux is
present or not. This study population was categorized into
three groups including patients with daytime, nighttime, or
combined reflux symptoms. This classification can precisely
elucidate the clinical characteristics andpsychosocial impact
of each group. In addition, this is the first study to investigate
the impact of different timings of reflux symptoms on anxiety
and depression using TDQ and STAI scores. However, some
limitations of our study should be acknowledged. First, a late
night snack may affect the risk of nighttime reflux.33 How-
ever, these data were not collected from each participant in
this study. Second, some drugs are known to increase the risk
of reflux symptoms and esophageal mucosal injury.34 In this
study, although the history of medication of each participant
was not recorded, this confounding effect might be minimal
due to fewer drug users in this relatively healthy population.
Finally, since this study was cross-sectional, the causal rela-
tionship could not be determined.
In summary, although GERD patients with combined reflux
symptoms have more troublesome symptoms than those with
daytime reflux, the timing of reflux symptoms has no influ-
ence on the development of erosive esophagitis, quality of
sleep, anxiety, and depression. In addition, GERD patients
with nocturnal or combined reflux symptoms have higher BMI
and education level than thosewith daytime reflux.Our study
confirms the hypothesis that GERD patients with different
timings of reflux symptoms have different clinical
128 J.-H. Chen et al.characteristics in terms of BMI and duration of education, but
not in terms of the presence of esophagitis on endoscopy,
quality of sleep, and psychosocial status.Acknowledgments
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